Nanopharmaceuticals, which are frequently employed in drug delivery, play a significant role in advanced healthcare. Nanopharmaceuticals are distinguished from other macroscopic levels of medicine by their shape and content, and they have several advantages over bulk equivalents, including precise targeting and patient compliance.
The global nanopharmaceuticals market size was valued at US$ 28,434.3 million in 2017, and is expected to exhibit a CAGR of 22.1 % over the forecast period (2021–2027).
Request Sample Copy of Nanopharmaceuticals Report @
Increasing prevalence of cancer and neurological diseases is expected to propel growth of the global nanopharmaceuticals market
Nanopharmaceuticals are used to treat a variety of ailments, including cancer, neurological disorders, and others. Furthermore, the rising global prevalence of cancer is likely to fuel market expansion. According to the World Health Organization’s (WHO) September 2018 factsheet, cancer claimed the lives of 9.6 million people worldwide, making it the second largest cause of death.
The worldwide nanopharmaceuticals market is predicted to rise due to rising occurrences of neurological disorders such as Alzheimer’s disease and Parkinson’s disease. According to the 2015 World Alzheimer Report, about 46 million individuals worldwide were diagnosed with dementia in 2015, with the number expected to rise to roughly 131.5 million by 2050.
However, the market’s expansion is projected to be hampered by potential toxicity risks and a lack of regulatory requirements. Carbon-based nanopharmaceuticals were found to be harmful in multiple in vitro and in vivo experiments, according to the P&T Community Journal, Volume 42, December 2017, Toxicology is thought to be caused by oxidative stress and other factors.
Rising prevalence of chronic diseases in North America is expected to drive the North America nanopharmaceuticals market growth
Because of increased research and development activity in the application of nanotechnology in pharmaceuticals and the rising frequency of chronic illnesses, North America dominates the worldwide nanopharmaceuticals market. According to a factsheet published by the Centers for Disease Control and Prevention (CDC), 6 out of 10 persons in the United States are diagnosed with chronic diseases, and 4 out of 10 persons have two chronic diseases. Chronic diseases account for over 75% of healthcare costs in the United States, according to the same source.
Key manufacturers in the region are focusing on creating and creating new pharmaceuticals to fulfil patient demands, which is projected to drive market growth over the forecast period. For example, in October 2012, Celgene Corporation, a U.S.-based company, received approval from the U.S. Food and Drug Administration (FDA) for Abraxane (paclitaxel protein-bound particles for injectable suspension), which is used for first-line treatment of advanced non-small cell lung cancer.
Furthermore, leading competitors in the market are concentrating their efforts on obtaining FDA clearance for novel products to treat patients. In May 2017, NovoNodisk got FDA clearance for glycopegylated Rebinyn, which is intended to control bleeding and manage bleeding in individuals with haemophilia B.
Request PDF Report Brochure @
Key performers operating in the global nanopharmaceuticals market include Abbott, GlaxoSmithKline plc., Eli Lilly and Company, Astrazeneca plc., Novavax, Inc., Stryker Corporation, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Tanabe Pharma Corporation, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma Inc., Navidea Biopharmaceuticals, Inc., AbbVie Inc., AMAG Pharmaceuticals, Amgen Inc., Astellas Pharma Inc., Celgene Corporation, Gilead Sciences, Inc., JOHNSON & JOHNSON, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Hoffmann-La Roche AG, Sanofi S.A, Shire Plc., and Teva Pharmaceuticals Industries Limited.
Reasons to Purchase this Report
• Current and future of global Nanopharmaceuticals market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
Table Of Content
Chapter No. 1 Introduction
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. USP & Key Offerings
1.2. Key Benefits for Stakehulders
1.3. Target Audience
1.4. Report Scope
Chapter No. 2 Executive Summary
2.1. Key Findings
2.1.1. Top Investment Pockets
184.108.40.206. Market Attractiveness Analysis, By Type
220.127.116.11. Market Attractiveness Analysis, By End Use
18.104.22.168. Market Attractiveness Analysis, By Region
2.2. Market Snapshot
2.3. Global Nanopharmaceuticals Market, 2016 – 2021 (USD Million)
2.4. Insights from Primary Respondents
Chapter No. 3 COVID 19 Impact Analysis
3.1. Impact Assessment of COVID-19 Pandemic, By Region
3.1.1. North America
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. The Middle-East and Africa
Key Questions Answered in This Report on Nanopharmaceuticals Market
• How much revenue will the global Nanopharmaceuticals Market generate by the end of the forecast period?
• What regions currently contribute the maximum share to the overall Nanopharmaceuticals Market?
• What are the indicators expected to drive the global Nanopharmaceuticals Market?
• Which region is likely to be a lucrative market during the forecast period?
• What are the essential strategies incorporated by key stakeholders in the global Nanopharmaceuticals Market to expand their geographical presence?
• What are the major advancements witnessed in the global Nanopharmaceuticals Market?
• This report answers these questions and more about the global Nanopharmaceuticals Market, aiding major stakeholders and key players in making the right decisions and strategizing for the advancement of their business.
Customization of the Report
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Also, Research Report Examines:
• Competitive companies and manufacturers in global market
• By Product Type, Applications & Growth Factors
• Industry Status and Outlook for Major Applications / End Users / Usage Area
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027